OBJECTIVES: A relation of prostate cancer risk with calcium, vitamin D and phosphorus has been suggested, but remains controversial. METHODS: A case-control study was conducted in Italy in 1991-2002. Cases were 1294 men with incident prostate cancer, and controls were 1451 men admitted to hospital for acute non-neoplastic diseases. Odds ratios (OR) and the corresponding 95% confidence intervals (CI) were estimated using unconditional multiple logistic regression. RESULTS: Compared to the lowest one quintile of dietary calcium intake the OR was 1.18 for the highest, 1.01 for an increment of 622 mg/day of calcium, and 1.29 (95% CI 0.78-2.13) for 2000 mg/day or more of calcium. The OR of prostate cancer for the highest quintile of dietary intake of vitamin D and phosphorus were 1.33 and 1.20 respectively. CONCLUSIONS: This study shows no material association of dietary intake of calcium, vitamin D and phosphorus with prostate cancer risk.
OBJECTIVES: A relation of prostate cancer risk with calcium, vitamin D and phosphorus has been suggested, but remains controversial. METHODS: A case-control study was conducted in Italy in 1991-2002. Cases were 1294 men with incident prostate cancer, and controls were 1451 men admitted to hospital for acute non-neoplastic diseases. Odds ratios (OR) and the corresponding 95% confidence intervals (CI) were estimated using unconditional multiple logistic regression. RESULTS: Compared to the lowest one quintile of dietary calcium intake the OR was 1.18 for the highest, 1.01 for an increment of 622 mg/day of calcium, and 1.29 (95% CI 0.78-2.13) for 2000 mg/day or more of calcium. The OR of prostate cancer for the highest quintile of dietary intake of vitamin D and phosphorus were 1.33 and 1.20 respectively. CONCLUSIONS: This study shows no material association of dietary intake of calcium, vitamin D and phosphorus with prostate cancer risk.
Authors: Rahul Ray; Mara Banks; Hilal Abuzahra; Vikram J Eddy; Kelly S Persons; M Scott Lucia; James R Lambert; Michael F Holick Journal: Anticancer Res Date: 2012-03 Impact factor: 2.480
Authors: Tomasz Golabek; Jakub Bukowczan; Robert Sobczynski; Jaroslaw Leszczyszyn; Piotr L Chlosta Journal: Arch Med Sci Date: 2016-04-12 Impact factor: 3.318
Authors: Sascha Venturelli; Christian Leischner; Thomas Helling; Olga Renner; Markus Burkard; Luigi Marongiu Journal: Cancers (Basel) Date: 2022-02-28 Impact factor: 6.639